- Home
- Clinical Trials
Inherited High Cholesterol Studies Auckland
Strive Inherited High Cholesterol Study Auckland
Auckland
We are inviting adults with inherited high cholesterol (heterozygous familial hypercholesterolaemia) to consider participation in a clinical research study. This inherited condition causes high levels of LDL (bad) cholesterol.
Researchers are studying an investigational gene-editing medicine for this condition by examining how the body responds to it.
Description
What to expect
Study details
Ages
18-65 years
Duration
The study will last approximately two years and will involve approximately 18 clinic visits.
Compensation
Participants will be paid for time and study-related costs.
Eligibility Criteria
You may qualify for this study if you:
• Are aged 18 to 65 years
• Have a diagnosis of heterozygous familial hypercholesterolaemia (Inherited high cholesterol))
• Have been taking at least two approved cholesterol-lowering medicines at stable doses for three months or longer
Other eligibility criteria will apply. Our study team will be able to assess whether this study is suitable for you.
Locations
Description
Heterozygous familial hypercholesterolaemia, often called HeFH, is an inherited condition that causes high levels of LDL (bad) cholesterol from birth. High LDL cholesterol levels can increase the risk of major cardiovascular events such as strokes or heart attacks. People with HeFH may continue to have high cholesterol even while taking cholesterol-lowering medicines.
This clinical research study will evaluate an investigational gene-editing medicine. The study aims to learn how the body processes it and how cholesterol levels change after it is given.
What to expect
The study will last approximately two years. Participants will receive one intravenous infusion into a vein and remain at an inpatient facility for at least 24 hours for observation. Medicines will be given before the infusion to reduce the chance of an infusion reaction.
Participation may also involve:
- Pre-study screening procedures for up to 45 days before treatment
- Regular clinic visits and study related assessments over approximately two years, including physical examinations, blood tests, heart tracing tests and MRI scans
- Continuing stable background cholesterol-lowering treatment as directed by the study doctor
Participation is voluntary. A member of the study team can explain the study, answer questions and assess whether it may be suitable for you.
Apply Now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. By clicking 'Submit' you agree to our Privacy Policy which contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.